TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today that Eisai has submitted an application in Japan for the additional iContinue Reading

TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a license agreement for development and distribution of vibegron, a therapeutic agent for overactive bladder, in four ASEContinue Reading

TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Fujitsu Limited today announced the establishment of Fujitsu Ventures Fund LLC, a corporate venture capital (CVC) fund totaling 10 billion yen, under the management by the subsidiary Fujitsu Ventures Limited. The new fund will targContinue Reading

TOKYO, Mar 30, 2021 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation’s production and sales results for February 2021 are summarized below. I. Production 1. Domestic ProductionMazda’s domestic production volume in February 2021 decreased 4.9% year on year due to dContinue Reading

TOKYO, Mar 30, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that the European Medicines Agency (EMA) has confirmed it has accepted for review applications for the use of its in-house discovered multiple receptor tyrosine kinase inhibitor, lenvatinib mesylate Continue Reading

YOKOHAMA, Japan, Mar 26, 2021 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Power, a subsidiary of Mitsubishi Heavy Industries (MHI) Group, has presented certificates of appreciation to three companies that, among its many suppliers, made especially noteworthy contributions to its busiContinue Reading